Smoking cessation therapy at Kobe City Medical Center West Hospital －Six-years’ experience since the establishment of the smoking cessation clinic－

DOI
  • Tomioka Hiromi
    Department of Respiratory Medicine,Kobe City Medical Center West Hospital, Kobe, Japan
  • Sekiya Reina
    Department of Respiratory Medicine,Kobe City Medical Center West Hospital, Kobe, Japan
  • Kaneda Toshihiko
    Department of Respiratory Medicine,Kobe City Medical Center West Hospital, Kobe, Japan
  • Kida Yoko
    Department of Respiratory Medicine,Kobe City Medical Center West Hospital, Kobe, Japan
  • Nishio Chihiro
    Department of Respiratory Medicine,Kobe City Medical Center West Hospital, Kobe, Japan
  • Nakamura Takehiro
    Respiratory Medicine,Kobe City Medical Center West Hospital, Kobe, Japan
  • Ishimoto Gakuji
    Diabetes and Endocrinology,Kobe City Medical Center West Hospital, Kobe, Japan
  • Itagaki Noriko
    Nursing, Kobe City Medical Center West Hospital, Kobe, Japan

Bibliographic Information

Other Title
  • 当院における禁煙外来の展開-開設への取り組みと約6年間の治療成績

Search this article

Abstract

We describe our 6 years’ experience with smoking cessation therapy at Kobe City Medical Center West Hospital. According to a questionnaire survey of hospitalized patients（ n=169） and outpatients（ n=645） that was conducted in January 2007, approximately 25% of patients were not in favor of the full-scale smoking cessation program conducted in our hospital. In August 2007, after careful preparations, we implemented the full-scale smoking cessation program in our hospital and established a smoking cessation clinic. Between August 2007 and March 2014, 606 patients with nicotine dependence participated in a 3-month smoking cessation program that was covered by the Japanese medical insurance system. The participants consisted of 377 men and 229 women whose age was 58±13 years（ mean±SD）. The Brinkman Index score was 868.0±540.9, and the exhaled CO level was 15.3±11.1 ppm. The underlying diseases included mental disorders（ 29.5%）, hypertension（ 18.2%）, diabetes（ 17.3%）, and cardiovascular diseases（ 16.7%）. The initial prescriptions was transdermal nicotine patches in 369 subjects and varenicline in 237 subjects. Of the 606 participants, 309（ 51.0%） completed the program, among whom 207（ 67.0%） succeeded in smoking cessation.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top